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Significance of Problem:
• Current attempts to alleviate pain 
during SLN injections have been 
ineffective, despite subcutaneous 
anesthetization. 
• Breast cancer patients at this facility 
are deeming this procedure to be 
most uncomfortable. 
• Breast cancer is the 2nd most common 
type of cancer diagnosed in U.S. 
females and the 2nd most prominent 
cause of cancer related death after 
lung cancer (Centers for Disease 
Control and Prevention [CDC], 2020). 
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Analysis of Literature via JHNEBP 
research evidence appraisal tools
(Dang & Darnholt, 2017)
Best Practices:
• Moderate level evidence within each of the studies supports GI as 
being beneficial for managing pain. 
• GI effective in the mitigation of pain, not its elimination.
• GI cost-effective, timely and feasible to implement.
• GI was found to be a viable CAM for pain mitigation within this 
procedural setting.
PICOT: 
Do women diagnosed with breast cancer 
undergoing SLN injections  report less 
procedural pain during SLN injections 
than women who do not use GI over 6 
months?
Implementation:
• Model followed: Johns Hopkins 
Nursing Evidence-Based Practice 
(JHNEBP).
• All available SLN patients presenting to 
the NAPBC surgeon’s office were 
contacted and consented to 
participate. 
• Educational pamphlet on GI provided.
• Participants were provided with a 5-
minute session of GI immediately prior 
to SLN injection. 
• Procedural pain scores were recorded 
via VAS and statistically compared to 
non-interventional group.
Evaluation: Primary Outcome
• Students t-test analysis was 
employed to compare post 
procedural pain ratings of the GI 
intervention group (n =6)  to the 
scores of the non-GI comparison 
group (n=13).  
• The statistical outcome between 
the intervention and comparison 
group was not significant in 
determining that the GI group 
reported less perceived pain ( t = 
2.864, p = 0.012). 
Conclusion & Recommendations:
• Mean pain scores were not lower within the GI group. However, 
the sample size of the intervention group was less than half of the 
comparison group.
• The mean pain score for the GI group was 6.67 (SD = 1.86) with a 
mean score of 3.46 (SD = 2.96) for the comparison (non-GI) group.
• This intervention was feasible, cost effective, and posed no delay in 
daily operations. Patients receptive to GI. 
• Further research would be useful in exploring how GI could be used 
within other procedural  settings using larger sample sizes. 
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